* Humanigen Inc HGEN.OQ HGEN.O is expected to show a
fall in
quarterly revenue when it reports results on August 10
(estimated).
* The Short Hills New Jersey-based company is expected to
report
a 49.8% decrease in revenue to $520 thousand from $1.04 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Humanigen Inc is
for a
loss of 30 cents per share. For the same quarter last year, the
company reported a loss of $1.20 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Humanigen
Inc is
$2, above its last closing price of $0.40.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.47 -0.46 -0.32 Beat 30.8
Dec. 31 2022 -0.68 -0.65 -0.53 Beat 18
Sep. 30 2021 -1.01 -0.98 -1.12 Missed -13.8
Jun. 30 2021 -0.83 -0.86 -1.20 Missed -39.3
Mar. -0.71 -0.64 -1.25 Missed -95.3
31 2021
Dec. 31 2020 -0.68 -0.67 -0.63 Beat 6.3
Sep. 30 2020 -0.57 -0.57 -0.71 Missed -25.3
This summary was machine generated August 8 at 11:03 GMT. All
figures in US dollars unless otherwise stated